Kursinformation
Aktuelle News
News Funktionen
Weitere Funktionen
13 Oktober 2021
NanoViricides, Inc.
NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug Program Rapidly Moving Towards Clinical Stage
27 Januar 2021
NanoViricides, Inc.
NanoViricides, Inc.: Broad-Spectrum Direct Antiviral Nanomedicine Should Remain Effective Against COVID-19 Virus Variants, Says NanoViricides, Inc.’s President, Dr. Anil Diwan
17 November 2020
NanoViricides, Inc.
NanoViricides Has Filed Quarterly Report for Period Ending September 30, 2020 – Has Sufficient Cash, Coronavirus Drug Development Progress
16 September 2020
NanoViricides, Inc.
NanoViricides Nominates a Novel Candidate for Advancing Into Clinical Trials for Treatment of COVID-19
21 Juli 2020
NanoViricides, Inc.
NanoViricides to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit Today, July 21, 2020
13 Juli 2020
NanoViricides, Inc.
NanoViricides Closes On $11.5 Million Underwritten Public Offering of Common Stock